However, when sold for "research" or "anti-aging" purposes outside of its approved indication, it falls into a regulatory gray area
Journal of controlled release
The same is true of PlexusDx Weight Management Protocols Semaglutide Injection and Tirzepatide Injection use compounded versions from licensed U.S
Acetyl-L Carnitine Market Outlook: Acetyl-L Carnitine Market size was over USD 94.18 million in 2025 and is projected to reach USD 165.51 million by 2035, growing at around 5.8% CAGR during the forecast period i.e., between 2026-2035
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the First-in-Class GLP-1 and Amylin Receptor Agonist, Amycretin: A First-in-Human, Phase 1, Double-Blind, Randomised, Placebo-Controlled Trial
Similar designs were applied to compare GLP-1RAs with metformin, DPP-4 inhibitors, sulfonylureas, thiazolidinediones, and insulins